Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

New Oral Drug Approved for Herpes Lesions

(MedPage Today) -- The FDA approved pritelivir (Hovilpri) tablets to treat mucocutaneous lesions caused by herpes simplex virus (HSV) infections in immunocompromised patients who haven't responded to other treatments. Pritelivir, an oral helicase...

New Oral Drug Approved for Herpes Lesions

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

More from Friday 9 October →